y 27632 has been researched along with cysteamine in 2 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (cysteamine) | Trials (cysteamine) | Recent Studies (post-2010) (cysteamine) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 3,307 | 60 | 666 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bebawy, M; Luk, F; Roseblade, A; Ung, A | 1 |
| An, L; Chang, S; Du, F; Du, Y; Hu, Y; Li, Y; Ling, P; Liu, J; Liu, Y; Liu, Z; Presicce, GA; Xu, B; Xue, F; Yang, L; Zhang, F; Zhu, X | 1 |
2 other study(ies) available for y 27632 and cysteamine
| Article | Year |
|---|---|
Targeting microparticle biogenesis: a novel approach to the circumvention of cancer multidrug resistance.
Topics: Acrylates; Amides; Antineoplastic Agents; Breast Neoplasms; Calcimycin; Cell Line, Tumor; Cell-Derived Microparticles; Cystamine; Cysteamine; Drug Resistance, Neoplasm; Female; Humans; Molecular Targeted Therapy; Oligopeptides; Pantetheine; Pyridines; Verapamil | 2015 |
Synergistic effect of cysteamine, leukemia inhibitory factor, and Y27632 on goat oocyte maturation and embryo development in vitro.
Topics: Amides; Animals; Cysteamine; Cystine Depleting Agents; Embryo Culture Techniques; Embryo, Mammalian; Enzyme Inhibitors; Goats; In Vitro Oocyte Maturation Techniques; Leukemia Inhibitory Factor; Pyridines | 2018 |